Eagle Materials (EXP) has seen its stock fall by over 20% recently due to profitability pressures and weak pricing, despite revenue growth driven by Cement and Recycled Paperboard segments. Management is investing heavily in capacity expansions and modernization to reduce costs and boost production. The company remains undervalued compared to peers and continues to return capital to shareholders while pursuing growth projects, making it a recommended long-term buy despite current challenges.
Eagle Materials stock performance is the focus, with Pluang platform data providing sector context. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Oct 15, 2026 03:23 WIB: Out of 83 priced US stocks, 16 rose and 67 fell. Notable movers include SSRM at USD 30.60 with a 1-day change of -7.52% and 100% buy order activity, HYMC at USD 16.39 down 6.72% also with 100% buy activity, and AUGO at USD 82.05 down 6.70%, likewise with 100% buy orders. Typical hold times on Pluang range from 0 to 1 days for these stocks.
Stephany Insurance LLC, a fourth-generation independent agency in Wexford, PA, is highlighted in a new 2026 guide for helping small businesses in Pittsburgh's North Hills identify and close insurance coverage gaps caused by rising premiums. The guide...
The Knowles-Rowland House, a $13.96 million redevelopment project by Bread of Life Inc., has opened in Midtown Houston, providing 31 permanent supportive housing units for individuals exiting chronic homelessness. The building, formerly a fire-damage...
ATLAS SP Partners, majority owned by Apollo funds, announced the pricing of $750 million senior notes due 2032 with a fixed 6.25% interest rate until November 2031, then switching to a floating rate based on SOFR plus a spread. The notes, issued by A...
Bending Spoons led market gainers with a 41.2% rise after Berkshire Hathaway increased its stake to 4% by investing an additional $330 million. Antelope Enterprise gained 36.4%, and NEXGEL rose 32.1% following a reverse stock split. Liquidia advanced...
The Law Offices of Frank R. Cruz is investigating Alignment Healthcare following a whistleblower lawsuit claiming the company misclassified $8-10 million in expenses to inflate its adjusted EBITDA and stock price. This alleged accounting manipulation...
